Literature DB >> 4629906

Primate biliary physiology. 8. The effect of phenobarbital upon bile salt synthesis and pool size, biliary lipid secretion, and bile composition.

R N Redinger, D M Small.   

Abstract

Phenobarbital, by inducing liver microsomal enzymes, may affect bile acid synthesis from cholesterol and thus alter the secretion of biliary lipids and the composition of bile. We, therefore, determined the effects of phenobarbital on bile flow, biliary lipid secretion, bile acid synthesis, and bile-acid pool size. Using an experimental preparation that allows controlled interruption of the enterohepatic circulation (1), we administered 5 mg/kg per day of phenobarbital to healthy Rhesus monkeys for 1-2 wk to achieve steady-state conditions. Three animals were studied with an intact enterohepatic circulation and three with a total bile fistula, each animal served as its own control. Total bile flow and secretion of bile salt, phospholipid, and cholesterol were measured every 24 h during steady-state conditions. Further, under conditions of an intact enterohepatic circulation bile-acid synthetic rate was measured in three animals and pool size estimated in two animals during both control and drug treatment periods. Phenobarbital at doses of 5 mg/kg per day increased bile flow 30-50% in all animals (P < 0.001). The increased bile flow resulted from both an increased "bile-salt independent fraction" and an increased bile-salt secretion rate. Phenobarbital significantly increased bile salt (P < 0.01) and phospholipid secretion (P < 0.05) by about 30% but cholesterol secretion was not significantly changed. Consequently, the concentration of cholesterol relative to bile salt and phospholipid was decreased (P < 0.001). Phenobarbital significantly enhanced the maximal rate of bile acid synthesis 25-30% in all three monkeys with total bile fistulas (P < 0.05) and also augmented bile acid synthesis and pool size in animals with intact enterohepatic circulations despite the fact that the rates of bile salt returning to the liver in these animals would have inhibited bile acid synthesis in control animals. Thus, phenobarbital not only increases the maximal rate of bile acid synthesis but also alters the normal control mechanisms by which bile salts returning to the liver inhibit bile salt synthesis. The fact that phenobarbital treatment results in increased synthesis of bile salt and unchanged secretion of cholesterol is consistant with the view that the drug augments conversion of hepatic cholesterol to bile salt. The resulting decrease in relative cholesterol content in bile may have therapeutic implications for cholesterol gallstone therapy.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4629906      PMCID: PMC302238          DOI: 10.1172/JCI107160

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

2.  C14-Cholesterol. III. Excretion of carbons 4 and 26 in feces, urine, and bile.

Authors:  M D SIPERSTEIN; I L CHAIKOFF
Journal:  J Biol Chem       Date:  1952-09       Impact factor: 5.157

3.  Possible role of P-450 in the oxidation of drugs in liver microsomes.

Authors:  R Kato
Journal:  J Biochem       Date:  1966-06       Impact factor: 3.387

4.  Biliary flow after microsomal enzyme induction.

Authors:  C D Klaassen
Journal:  J Pharmacol Exp Ther       Date:  1969-08       Impact factor: 4.030

5.  Participation of P-450 in 7 alpha-hydroxylation of cholesterol.

Authors:  F Wada; K Hirata; K Nakao; Y Sakamoto
Journal:  J Biochem       Date:  1968-09       Impact factor: 3.387

6.  Increased bilirubin conjugation in heterozygous Gunn rats treated with phenobarbital.

Authors:  S H Robinson
Journal:  Nature       Date:  1969-06-07       Impact factor: 49.962

7.  Effects of phenobarbital on biliary excretion of organic acids in male and female rats.

Authors:  L G Hart; A M Guarino; R H Adamson
Journal:  Am J Physiol       Date:  1969-07

8.  Feedback regulation of bile acid biosynthesis in the rat.

Authors:  S Shefer; S Hauser; I Bekersky; E H Mosbach
Journal:  J Lipid Res       Date:  1969-11       Impact factor: 5.922

9.  A method for quantitative determination of bile acids in human feces. Bile acids and steroids 195.

Authors:  P Eneroth; K Hellström; J Sjövall
Journal:  Acta Chem Scand       Date:  1968

10.  Phenobarbital-induced alterations in phosphatidylcholine and triglyceride synthesis in hepatic endoplasmic reticulum.

Authors:  D L Young; G Powell; W O McMillan
Journal:  J Lipid Res       Date:  1971-01       Impact factor: 5.922

View more
  22 in total

1.  Increase in serum cholesterol during phenytoin treatment.

Authors:  R Pelkonen; R Fogelholm; E A Nikkilä
Journal:  Br Med J       Date:  1975-10-11

2.  The effect of bile acid synthesis on cholesterol secretion into the bile.

Authors:  S M Strasberg; R G Ilson
Journal:  Ann Surg       Date:  1975-04       Impact factor: 12.969

3.  The effect of phenobarbital on biliary lipid metabolism and hepatic microsomal drug metabolism in patients with cholesterol cholelithiasis.

Authors:  G W Hepner
Journal:  Am J Dig Dis       Date:  1976-05

4.  Changes in in vivo metabolism of bile acids in rat after treatment with phenobarbital.

Authors:  T Cronholm; K Einarsson; J A Gustafsson
Journal:  Lipids       Date:  1974-11       Impact factor: 1.880

5.  The present position concerning gallstone dissolution.

Authors:  G D Bell
Journal:  Gut       Date:  1974-11       Impact factor: 23.059

6.  The control of bile acid pool size: effect of jejunal resection and phenobarbitone on bile acid metabolism in the rat.

Authors:  H Y Mok; P M Perry; R H Dowling
Journal:  Gut       Date:  1974-04       Impact factor: 23.059

7.  Effect of phenobarbital, spironolactone and pregnenolone-16 alpha-carbonitrile on bile formation in the rat.

Authors:  K von Bergmann; H P Schwarz; G Paumgartner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

8.  Hypersecretion of biliary fatty acids in patients with exocrine pancreatic disease.

Authors:  M Taj; P Rose; L P Hunt; G N Smith; J M Braganza
Journal:  Int J Pancreatol       Date:  1986-12

9.  Modifications of liver bile acids pool during modulation of rat hepatocarcinogenesis by phenobarbital and nafenopin.

Authors:  N M Delzenne; H S Taper; M Roberfroid
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

10.  Paracetamol disposition in normal subjects and in patients treated with antiepileptic drugs.

Authors:  E Perucca; A Richens
Journal:  Br J Clin Pharmacol       Date:  1979-02       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.